Cyted Health’s Post

Congratulations to Joseph DeRisi, Ph.D. and Aaron Bodansky, MD for the publication of their research in Nature! Our illustration visualizes an extremely detailed example of molecular mimicry occurring within children with multi system inflammatory syndrome (MIS-C), an autoimmune-mediated illness in patients following COVID-19 infection. Our visuals capture the essence of DeRisi and Bodansky’s findings, illustrating the cross reactive CD8 T cells that mediate coronavirus infection then go on to bind a child's native SNX8, a globular protein (nearly identical to the SARS-Cov-2 nucleocapsid protein) implicated with MIS-C patients. #CZBiohubSF Chan Zuckerberg Biohub Network Paper: https://lnkd.in/g5GUddBX CZBioHub Article: https://lnkd.in/g2n67jvj

There is no R&D for New Antibiotics by any company and there are lot's of R& D for Anticancer drugs or any other drugs which can give the company revenue back. For Antibiotics, the saying goes " A PHARMACEUTICAL COMPANY TAKES 20 YEARS TO R& D OR SYNTHESIZE A NEW MOLECULE, BUT THE BACTERIA TAKES 20 SECONDS TO FIND A RESISTANCE ". So the question is which company will take the risk?

"🔍 Validating Artificial Intelligence (AI) digital diagnostics in Infectious Disease Diagnostics 🧬 The rise of AI-based digital diagnostics is capturing significant attention. Have you ever pondered how these methods compare to DNA-based amplification-detection (real-time PCR), antigen-based diagnostics (UCP-LF CAA), and conventional microscopy in diagnosing infectious diseases, particularly in field settings on banked and fresh samples? Curious to delve deeper? Click the link to read more about our recent publication. [https://lnkd.in/ev6dmE9V] #AI-based digital diagnostics #DigitalHealth #Schistoscope #pcr # microscopy #caa #InfectiousDisease #Schistosomiasis #banked samples Prosper Oyibo, Pytsje T Hoekstra, Paul Alvyn Nguema Moure, Moustapha Nzamba Maloum, Romeo Aime Laclong-Lontchi, Yabo Josiane Honkpehedji, Michel Bengtson, Cornelis Hokke, Paul L A M Corstjens, Temitope Agbana, Jan Carel Diehl, Ayola Akim Adegnika, Lisette van Lieshout

Next week, September 16-22, is the World Mitochondrial Disease Week and we are calling for awareness of mitochondrial diseases. One of the key events is Light Up for Mito on September 21, where buildings around the world will light up green to support those affected by mitochondrial diseases. 🌍💚 🔬 We at baseclick are proud to be part of the MITGEST_EU consortium, an EU-funded project that actively contributes to mitochondrial research and develops innovative methods for the targeted treatment of mitochondrial diseases. 💡 In our project, we are using our technology to explore innovative ways to deliver RNA and oligonucleotides directly into the mitochondrial matrix. By combining this with mitochondria-targeting peptides and cellular delivery strategies, we aim to develop new approaches for effective mitochondrial therapies. Let's work together to elucidate these important advances while supporting global efforts to raise awareness! 💚 #WorldMitoWeek2024 #IlluminateTomorrow #MitochondrialDisease #LightUpForMito #MITGEST_EU #baseclick #thelilyfoundation #Research #CellTrageting #CellSpecificDelivery

Introducing the hDPP4 mouse from Taconic Biosciences! This model is vital for MERS-CoV research, helping you study disease progression and test potential treatments. With a live production colony and easy label licensing, it's now more accessible for your research needs. Discover the new model: https://hubs.li/Q02R3BFN0

Today we honor #RareDiseaseDay and especially 6-year-old Sophie, a special friend of SomaLogic. We're honored that our SomaScan® Assay has been used to discover valuable insights into the rare disease she lives with – Multicentric Carpotarsal Osteolysis (MCTO). Show your support with these unique RARE bracelets now on sale through February 29 as part of a collaboration with Sophie's Neighborhood and Threads Worldwide: https://lnkd.in/gQQMYUCD Are you researching rare diseases? Here's how to uncover clues to disease progression and assess therapy effectiveness with the SomaScan Assay: https://lnkd.in/gjqfcjFS #biomarkers #proteomics

Liquid biopsy is the topic of this episode. How can these biopsies find biomarkers for disease in a less invasive manner? Let’s find out. https://lnkd.in/dn5T7W5R #liquidbiopsy #DiscoveryMatters #biomarkers

Using HiFi sequencing, researchers can now uncover new structural variants and gain deeper insights into rare disease like never before. However, many families, like Laura and Dave, are still searching for answers. Events like the Wilhelm Foundation’s 'Undiagnosed Hackathon', in collaboration with Radboudumc, highlight the importance of working together to drive new discoveries and help provide critical insights for families like Laura and Dave's. Learn more about how PacBio is bringing new hope to rare disease research: https://bit.ly/3vxb5y2 #RareDiseaseResearch #RareDisease #ASHG24

Modern healthcare is remarkable! Rapid diagnostic tests for various conditions are now a reality, thanks to advances in technology. Most new tests use simple immunoassays, which rely on antibody-antigen interactions. These advances are transforming disease detection and treatment for cancer, infections, and autoimmune disorders. Stay ahead and explore the latest trends in immunodiagnostics shaping the future of disease detection. #CytivaDx #Diagnostics #Immunoassays

Liquid biopsy is the topic of this episode. How can these biopsies find biomarkers for disease in a less invasive manner? Let’s find out. https://lnkd.in/gucRRqFC #liquidbiopsy #DiscoveryMatters #biomarkers